Biocon Limited (BOM:532523)
India · Delayed Price · Currency is INR 425.65
+0.10 (0.02%)
At close: Jul 31, 2026
Biocon Market Cap
Biocon has a market cap or net worth of 689.42 billion as of July 31, 2026. Its market cap has increased by 30.04% in one year.
Market Cap
689.42B
Enterprise Value
830.83B
Revenue
169.27B
Ranking
n/a
PE Ratio
178.79
Stock Price
425.65
ChartMarket Cap Chart
Since April 7, 2004, Biocon's market cap has increased from 45.41B to 689.42B, an increase of 1,418.12%. That is a compound annual growth rate of 12.95%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 31, 2026 | 689.42B | 31.16% |
| Dec 31, 2025 | 525.64B | 20.22% |
| Dec 31, 2024 | 437.25B | 46.69% |
| Dec 29, 2023 | 298.08B | -4.59% |
| Dec 30, 2022 | 312.41B | -27.97% |
| Dec 31, 2021 | 433.73B | -21.37% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Aarti Drugs | 38.65B |
| Hester Biosciences | 21.11B |
| Titan Biotech | 17.28B |
| CCME Global | 4.97B |
| Zenotech Laboratories | 2.72B |
| Bharat Immunologicals & Biologicals Corporation | 664.97M |
| Transgene Biotek | 228.07M |
| Hindustan Bio Sciences | 73.81M |